New Nordic Diet-Induced Weight Loss Is Accompanied by Changes in Metabolism and AMPK Signaling in Adipose Tissue

J Clin Endocrinol Metab. 2015 Sep;100(9):3509-19. doi: 10.1210/jc.2015-2079. Epub 2015 Jun 30.

Abstract

Context: The molecular mechanisms behind diet-induced metabolic improvements remain to be studied.

Objective: This study sought to investigate whether expression of proteins in skeletal muscle or adipose tissue could explain improvements in glucose and lipid homeostasis after weight loss.

Design: Volunteers consumed a New Nordic Diet (NND) or an Average Danish Diet for 26 weeks in a controlled, free-living setting.

Subjects: Sixty four moderately obese women and men (44 ± 2 y; body mass index, 31 ± 1 kg/m(2)).

Intervention: Fasting blood samples and biopsies from the vastus lateralis muscle and subcutaneous abdominal adipose tissue (SCAT) were obtained at week 0 and 26.

Outcome: Gene and protein expressions were analyzed by real-time PCR and Western blotting.

Results: Improved homeostasis homeostatic model of assessment-insulin resistance index and lowered plasma triacylglycerol concentration after NND coincided with molecular adaptations in SCAT but not in skeletal muscle. NND induced greater reduction in fat mass than ADD (-6 ± 1 kg and -2 ± 1 kg; P < .01). In SCAT this was associated with increased AMPK and acetyl-CoA carboxylase phosphorylation (P < .05). Concomitantly, NND induced up-regulation of Akt2 and Akt substrate of 160 kDa (P < .05) as well as fatty acid transport protein 4 and membrane associated fatty acid binding protein (P < .05). Indices of increased oxidative capacity were observed, as carnitine palmitoyl transferase 1 mRNA (P = .08) as well as citrate synthase (P = .1) and cytochrome c (P = .05) protein tended to increase.

Conclusion: NND-induced metabolic improvements were accompanied by increased AMPK signaling in SCAT, suggesting a role of AMPK in these adaptations. The concomitant up-regulation of key glucose and lipid-handling proteins suggests an improved metabolic capacity in adipose tissue after weight loss.

Trial registration: ClinicalTrials.gov NCT01195610.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / metabolism*
  • Adipose Tissue / metabolism*
  • Adult
  • Blood Glucose / metabolism
  • Body Mass Index
  • Diet, Reducing / methods*
  • Energy Metabolism / physiology*
  • Female
  • Humans
  • Insulin Resistance / physiology
  • Male
  • Middle Aged
  • Muscle, Skeletal / metabolism
  • Obesity / diet therapy*
  • Obesity / metabolism
  • Signal Transduction / physiology*
  • Weight Loss / physiology*

Substances

  • Blood Glucose
  • AMP-Activated Protein Kinases

Associated data

  • ClinicalTrials.gov/NCT01195610